Antisense oligonucleotides (ASOs) targeting periostin lowered hepatic steatosis in conjunction with reduced expression of α-SMA, collagen I, and other fibrotic markers and increased expression levels of PPAR-α. This evidence concerns the gene POSTN and fatty liver disease.